Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates - Trial NCT06206590
Access comprehensive clinical trial information for NCT06206590 through Pure Global AI's free database. This phase not specified trial is sponsored by Guangdong Women and Children Hospital and is currently Recruiting. The study focuses on Neonatal Disease. Target enrollment is 116 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Guangdong Women and Children Hospital
Timeline & Enrollment
N/A
Nov 01, 2023
Dec 31, 2025
Primary Outcome
The incidence and mortality of shock
Summary
1. Explore 32 weeks of premature infants or maternal pregnancy infection of newborn septic
 shock maternal influence factors. 2. Through maternal blood samples before delivery and labor
 cord blood sample screening and septic shock related proteomics analysis, explore the
 relationship between the difference protein and septic shock and prognosis, and explore the
 pathway mechanism, in order to prevent and reduce the occurrence of septic shock in premature
 infants
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06206590
Non-Device Trial